The Goldman Sachs Group Lowers Kenvue (NYSE:KVUE) Price Target to $19.00

Key Points

• The Goldman Sachs Group has lowered its price target for Kenvue (NYSE:KVUE) from $22.00 to $19.00, maintaining a "neutral" rating on the stock.
• Kenvue's recent stock performance shows a trading price of $15.73, which is below its one-year high of $25.17, with a consensus target price of $22.46 from various analysts.
• Institutional investors own 97.64% of Kenvue's stock, with significant increases in holdings from firms like GAMMA Investing LLC and NBC Securities Inc. during the first quarter.

Kenvue (NYSE:KVUE - Get Free Report) had its price objective dropped by research analysts at The Goldman Sachs Group from $22.00 to $19.00 in a report released on Thursday,Benzinga reports. The firm presently has a "neutral" rating on the stock. The Goldman Sachs Group's target price suggests a potential upside of 20.83% from the stock's current price.

A number of other equities analysts have also recently issued reports on KVUE. Evercore ISI dropped their price objective on shares of Kenvue from $23.00 to $18.00 and set an "in-line" rating for the company in a research note on Tuesday, September 23rd. UBS Group cut their price target on shares of Kenvue from $25.00 to $23.00 and set a "neutral" rating for the company in a report on Thursday, July 17th. JPMorgan Chase & Co. decreased their price objective on shares of Kenvue from $27.00 to $26.00 and set an "overweight" rating on the stock in a research note on Friday, July 25th. Redburn Partners set a $22.00 target price on Kenvue in a report on Friday, September 26th. Finally, Royal Bank Of Canada reduced their target price on Kenvue from $24.00 to $22.00 and set a "sector perform" rating on the stock in a report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $22.46.

Kenvue Stock Performance

Shares of Kenvue stock traded down $0.13 during trading on Thursday, reaching $15.73. The company's stock had a trading volume of 16,452,144 shares, compared to its average volume of 20,187,613. Kenvue has a one year low of $15.47 and a one year high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98. The firm has a market cap of $30.18 billion, a price-to-earnings ratio of 21.29, a price-to-earnings-growth ratio of 2.33 and a beta of 0.73. The business's fifty day moving average price is $19.99 and its 200-day moving average price is $21.68.

Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.28 by $0.01. The firm had revenue of $3.84 billion for the quarter, compared to analyst estimates of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The company's revenue was down 4.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities research analysts predict that Kenvue will post 1.14 earnings per share for the current year.

Institutional Trading of Kenvue

A number of large investors have recently made changes to their positions in KVUE. GAMMA Investing LLC increased its holdings in Kenvue by 3,092.9% during the 1st quarter. GAMMA Investing LLC now owns 594,176 shares of the company's stock worth $14,248,000 after purchasing an additional 575,567 shares in the last quarter. NBC Securities Inc. increased its holdings in Kenvue by 89,208.3% during the 1st quarter. NBC Securities Inc. now owns 10,717 shares of the company's stock worth $256,000 after purchasing an additional 10,705 shares in the last quarter. Merit Financial Group LLC increased its holdings in Kenvue by 237.8% during the 1st quarter. Merit Financial Group LLC now owns 37,481 shares of the company's stock worth $899,000 after purchasing an additional 26,387 shares in the last quarter. RFG Advisory LLC increased its holdings in Kenvue by 34.5% during the 1st quarter. RFG Advisory LLC now owns 20,386 shares of the company's stock worth $489,000 after purchasing an additional 5,233 shares in the last quarter. Finally, HF Advisory Group LLC increased its holdings in Kenvue by 8.0% during the 1st quarter. HF Advisory Group LLC now owns 122,888 shares of the company's stock worth $2,947,000 after purchasing an additional 9,150 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.